These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30170240)

  • 61. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
    Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses.
    Senger T; Becker MR; Schädlich L; Waterboer T; Gissmann L
    J Virol; 2009 Dec; 83(24):12692-701. PubMed ID: 19793806
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9.
    Zhai L; Peabody J; Pang YS; Schiller J; Chackerian B; Tumban E
    Antiviral Res; 2017 Nov; 147():116-123. PubMed ID: 28939477
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Naturally Occurring Major and Minor Capsid Protein Variants of Human Papillomavirus 45 (HPV45): Differential Recognition by Cross-Neutralizing Antibodies Generated by HPV Vaccines.
    Godi A; Facchetti A; Bissett SL; Cocuzza C; Miller E; Beddows S
    J Virol; 2015 Dec; 90(6):3247-52. PubMed ID: 26719255
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes.
    Kalnin K; Chivukula S; Tibbitts T; Yan Y; Stegalkina S; Shen L; Cieszynski J; Costa V; Sabharwal R; Anderson SF; Christensen N; Jagu S; Roden RBS; Kleanthous H
    Vaccine; 2017 Sep; 35(37):4942-4951. PubMed ID: 28778613
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.
    Chen J; Wang D; Wang Z; Wu K; Wei S; Chi X; Qian C; Xu Y; Zhou L; Li Y; Zhang S; Li T; Kong Z; Wang Y; Zheng Q; Yu H; Zhao Q; Zhang J; Xia N; Li S; Gu Y
    J Virol; 2023 Mar; 97(3):e0181922. PubMed ID: 36815785
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Displaying 31RG-1 peptide on the surface of HPV16 L1 by use of a human papillomavirus chimeric virus-like particle induces cross-neutralizing antibody responses in mice.
    Chen X; Zhang T; Liu H; Hao Y; Liao G; Xu X
    Hum Vaccin Immunother; 2018; 14(8):2025-2033. PubMed ID: 29683766
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions.
    Smith JF; Brownlow M; Brown M; Kowalski R; Esser MT; Ruiz W; Barr E; Brown DR; Bryan JT
    Hum Vaccin; 2007; 3(4):109-15. PubMed ID: 17611417
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantitative and epitope-specific antigenicity analysis of the human papillomavirus 6 capsid protein in aqueous solution or when adsorbed on particulate adjuvants.
    Li M; Wang X; Cao L; Lin Z; Wei M; Fang M; Li S; Zhang J; Xia N; Zhao Q
    Vaccine; 2016 Aug; 34(37):4422-8. PubMed ID: 27426626
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.
    Almanza H; Cubillos C; Angulo I; Mateos F; Castón JR; van der Poel WH; Vinje J; Bárcena J; Mena I
    J Clin Microbiol; 2008 Dec; 46(12):3971-9. PubMed ID: 18842943
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16.
    Guan J; Bywaters SM; Brendle SA; Ashley RE; Makhov AM; Conway JF; Christensen ND; Hafenstein S
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29211035
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interactions between papillomavirus L1 and L2 capsid proteins.
    Finnen RL; Erickson KD; Chen XS; Garcea RL
    J Virol; 2003 Apr; 77(8):4818-26. PubMed ID: 12663788
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of an HPV vaccine for a broad spectrum of high-risk types.
    Kanda T; Kondo K
    Hum Vaccin; 2009; 5(1):43-5. PubMed ID: 18690012
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.
    Kwak K; Jiang R; Wang JW; Jagu S; Kirnbauer R; Roden RB
    PLoS One; 2014; 9(5):e97232. PubMed ID: 24816794
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Persistent antibodies to HPV virus-like particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV.
    Malik ZA; Hailpern SM; Burk RD
    Viral Immunol; 2009 Dec; 22(6):445-9. PubMed ID: 19951181
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neutralization of human papillomavirus by specific nanobodies against major capsid protein L1.
    Minaeian S; Rahbarizadeh F; Zarkesh-Esfahani SH; Ahmadvand D; Broom OJ
    J Microbiol Biotechnol; 2012 May; 22(5):721-8. PubMed ID: 22561868
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of a major neutralizing epitope on human papillomavirus type 16 L1.
    White WI; Wilson SD; Palmer-Hill FJ; Woods RM; Ghim SJ; Hewitt LA; Goldman DM; Burke SJ; Jenson AB; Koenig S; Suzich JA
    J Virol; 1999 Jun; 73(6):4882-9. PubMed ID: 10233949
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of the mimotopes within the major capsid protein L1 of human papillomavirus types 18 and 45, using neutralizing monoclonal antibodies.
    Li N; Zhang G; Chen Y; Zhou J; Hui C; Li S; Liu H; Liu Y; Qi Y; Wang A
    Int J Biol Macromol; 2021 Mar; 174():587-595. PubMed ID: 33493568
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications.
    Fleury MJ; Touzé A; Maurel MC; Moreau T; Coursaget P
    Protein Sci; 2009 Jul; 18(7):1425-38. PubMed ID: 19533761
    [TBL] [Abstract][Full Text] [Related]  

  • 80. p120 catenin recruits HPV to γ-secretase to promote virus infection.
    Harwood MC; Dupzyk AJ; Inoue T; DiMaio D; Tsai B
    PLoS Pathog; 2020 Oct; 16(10):e1008946. PubMed ID: 33085724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.